Directorate change

Summary by AI ^BETAClose X

CQS New City High Yield Fund Limited announced a change in its Directorate, with Andrew Jonathan Dann appointed as Chair of the Audit and Risk Committee effective December 4, 2025, succeeding Wendy Jane Dorman who retired on the same date. Dann, a Chartered Accountant and existing Director since February 1, 2025, has prior experience on the Company's Audit and Risk Committee, and the Board is confident in his continued support of the company's governance and risk management framework.

Disclaimer*

CQS New City High Yield Fund Ltd

05 December 2025

5 December 2025

CQS New City High Yield Fund Limited

(the Company)

Directorate Change

The Board announces that Andrew Jonathan Dann has been appointed Chair of the Audit and Risk Committee (ARC), effective 4 December 2025, succeeding Wendy Jane Dorman who retired from the Board on 4 December 2025.

Andrew Dann, a current Director of the Company since 1 February 2025, brings extensive experience as a Chartered Accountant and has served on the Company's ARC Board. The Board is confident that his expertise will continue to support the Company's robust governance and risk‑management framework.

This announcement is released in compliance with UK Listing Rule 6.4.6.

ENQUIRIES

Investment Manager

Manulife |CQS Investment Management

Craig Cleland

0207 201 5368

Company Secretary and Administrator

BNP Paribas S.A., Jersey Branch

Guerhardt Lamprecht

01534 813 959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END